Nanostring Technologies Inc

FDA Filings

This page includes the latest FDA filings for Nanostring Technologies Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Registration(s)

• Registration Number: 3006389928
• FEI Number: 3006389928
• Name: NanoString Technologies, Inc.
• Owner & Operator: NanoString Technologies, Inc.
• Contact Address: 530 Fairview Ave N ; Seattle WA 98109 US
• Official Correspondent:
  • Mirna DiPano
  • x-206-5522748-x
• Registration Status: 1
• Initial Importer: N
• Registration Expiration: 2020-04-25
• Registration Address: 530 Fairview Ave N ; Seattle, WA 98109 US
• Establishment Type:
  • Complaint File Establishment per 21 CFR 820.198
  • Manufacture Medical Device for Another Party (Contract Manufacturer)

FDA Filings

Device Company	Device	Date
GUDID 00859812006058 NANOSTRING TECHNOLOGIES, INC.	Prosigna Breast Cancer Prognostic Gene Signature Assay PROSIGNA-010	2020-02-06
GUDID 00859812006041 NANOSTRING TECHNOLOGIES, INC.	Prosigna Breast Cancer Prognostic Gene Signature Assay PROSIGNA-004	2020-02-06
GUDID 00859812006034 NANOSTRING TECHNOLOGIES, INC.	Prosigna Breast Cancer Prognostic Gene Signature Assay PROSIGNA-003	2020-02-06
GUDID 00859812006027 NANOSTRING TECHNOLOGIES, INC.	Prosigna Breast Cancer Prognostic Gene Signature Assay PROSIGNA-002	2020-02-06
GUDID 00859812006010 NANOSTRING TECHNOLOGIES, INC.	Prosigna Breast Cancer Prognostic Gene Signature Assay PROSIGNA-001	2020-02-06
GUDID 00859812006065 NANOSTRING TECHNOLOGIES, INC.	nCounter Prep Station 5s NCT-PREP-STATION-FLEX	2019-12-30
GUDID 00859812006003 NANOSTRING TECHNOLOGIES, INC.	nCounter Digital Analyzer 5s NCT-DIGITAL-ANALYZER-FLEX	2019-12-30
PMN K141771 | NYI NanoString Technologies, Inc.	Prosigna(R) Breast Cancer Prognostic Gene Signature Assay	2015-11-02
PMN K141771 NANOSTRING TECHNOLOGIES INC.	PROSIGNA BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY	2014-11-07
PMN K130010 | NYI NanoString Technologies, Inc.	Prosigna(R) Breast Cancer Prognostic Gene Signature Assay	2013-09-17
PMN K130010 | NSU NanoString Technologies, Inc.	Prosigna(R) Breast Cancer Prognostic Gene Signature Assay	2013-09-17
NYI NanoString Technologies, Inc.	Prosigna(R) Breast Cancer Prognostic Gene Signature Assay	2012-11-15

Related Finance Registrations

NCAGE Code	5DN29	NANOSTRING TECHNOLOGIES, INC.
CAGE Code	5DN29	NANOSTRING TECHNOLOGIES, INC.
S.A.M. Registration	5DN29 [143888712]	NANOSTRING TECHNOLOGIES, INC.
SEC	0001401708	NanoString Technologies Inc of DELAWARE

U.S. Import Records [external site]

Import ID	Shipment	Cargo Description	Quantity
2020071470518	Tokyo ,Japan -> Tacoma, Washington	STRIP TIPS SHEATHS	1034 CTN
2020071470520	Tokyo ,Japan -> Tacoma, Washington	PREP STATION	7 CAS
2020051237986	Tokyo ,Japan -> Tacoma, Washington	PIERCER CAPS	10 CAS
2020042435529	Tokyo ,Japan -> Tacoma, Washington	PIERCER CAPS	259 CTN
2020041045457	Tokyo ,Japan -> Tacoma, Washington	ARTICLES OF PLASTICS	310 CTN
2020040665415	Tokyo ,Japan -> Tacoma, Washington	ARTICLES OF PLASTICS	310 CTN
2020033155231	Tokyo ,Japan -> Tacoma, Washington	ELECTRO-MEDICAL APPARTUS	13 CAS
2020033056390	Tokyo ,Japan -> Tacoma, Washington	ELECTRO-MEDICAL APPARTUS	13 CAS